ALPL, variants, traits, and what the research shows

ALPL - what this gene does

Variants in this gene are consistently associated with rare disease traits. The data on file covers 628 total variants, and every variant in the current listing carries a high-magnitude rare disease signal.

Key takeaways

• All 20 listed variants are linked to rare disease, each with a magnitude score of 5.50.
• This gene has 628 total variants catalogued, reflecting active research interest in the rare disease space.
• The rare disease signal appears across many independent variants, which adds weight to the overall association.
• Detailed effect sizes and study-level data are not yet available in the current summaries.
• These variants are population-level signals, not personal health predictors.

Notable variants

The variants rs121918000, rs121918006, rs121918008, rs121918015, rs121918017, and rs121918018 all carry a magnitude score of 5.50 and are classified under the rare disease trait category. rs11586344 and rs1015578994 share the same trait classification and magnitude, completing a set of high-magnitude findings that together characterize the gene's association profile.

Trait associations

Every variant currently listed for this gene falls under the rare disease trait category. This includes rs1057516230, rs1057516293, rs1057516526, rs1057516702, rs1057517321, rs1057524727, rs1114167438, rs1131691372, rs1172381352, and rs1205971311, among others. The consistency of the rare disease signal across all 20 listed variants, drawn from a pool of 628 on file, suggests a strong thematic association. Repeated appearance of the same trait category across independent variants strengthens the overall classification.

Evidence quality

All 20 variants listed here carry a uniform magnitude score of 5.50 under a rare disease trait label. No sample sizes, odds ratios, beta coefficients, or study-level metadata are available in the current dataset; prior SNP summaries have not yet been generated for this gene. With 628 total variants on file and 18 flagged for prior research (none yet summarized in this entry), the full evidence base is substantially larger than what is shown here. The most important caveat is that without summary-level data, effect sizes and replication status cannot be assessed from this source alone, and the significance of individual variants may vary considerably.

What this is NOT

These variants are population-level statistical signals from genomic research, not deterministic predictors for any individual. Nothing here constitutes medical advice, a diagnosis, or a recommendation to take any action.